Highly Leveraged Pharmaceuticals Companies

Total Debt
Total DebtEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
5.46 T
 0.16 
 1.24 
 0.20 
2PFE Pfizer Inc
75.04 B
 0.12 
 1.31 
 0.16 
3BMY Bristol Myers Squibb
41.46 B
 0.15 
 2.14 
 0.31 
4MRK Merck Company
36.27 B
(0.08)
 1.77 
(0.15)
5JNJ Johnson Johnson
30.43 B
 0.20 
 1.08 
 0.21 
6AZN AstraZeneca PLC ADR
28.62 B
 0.01 
 1.18 
 0.01 
7NVO Novo Nordisk AS
27.01 B
 0.00 
 2.38 
(0.01)
8NVS Novartis AG ADR
26.35 B
 0.15 
 1.08 
 0.17 
9LLY Eli Lilly and
25.23 B
 0.05 
 2.34 
 0.12 
10BHC Bausch Health Companies
22.39 B
 0.01 
 3.72 
 0.04 
11TEVA Teva Pharma Industries
20.15 B
 0.05 
 2.10 
 0.10 
12RDY Dr Reddys Laboratories
20.02 B
 0.15 
 1.38 
 0.21 
13SNY Sanofi ADR
18.42 B
 0.22 
 1.42 
 0.31 
14VTRS Viatris
18.38 B
 0.15 
 1.86 
 0.28 
15GSK GlaxoSmithKline PLC ADR
18.02 B
 0.09 
 1.33 
 0.12 
16OGN Organon Co
8.76 B
 0.02 
 2.34 
 0.04 
17ZTS Zoetis Inc
6.8 B
 0.13 
 1.46 
 0.19 
18JAZZ Jazz Pharmaceuticals PLC
5.8 B
(0.06)
 1.74 
(0.10)
19ELAN Elanco Animal Health
5.77 B
(0.09)
 3.42 
(0.31)
20CTLT Catalent
4.99 B
 0.21 
 0.61 
 0.13 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.